Ceftizoxime/metronidazole replaces cefotetan for intra-abdominal infections

Formulary

Volumn 32, Issue 7, 1997, Pages 740-745

  Quintiliani, Richard ^a,b   Hitt, Catherine M ^c   Ambrose, Paul G ^a   Nicolau, David P ^a   Nightingale, Charles H ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c ST MARY S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; METRONIDAZOLE; SULBACTAM;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEROIDES FRAGILIS; DRUG COST; DRUG FEVER; ESCHERICHIA COLI; HUMAN; HYPERBILIRUBINEMIA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PROTEUS MIRABILIS; RASH;

EID: 0030802530     PISSN: 00986909     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH. Formulary replacement policies: Cefotetan vs cefoxitin. Infect Med 1987;4:275-9.
2. Goldstein EJC, Citron DM, Cherbun CE. Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrob Agents Chemother 1991;35:560-6.
3. Jones RN, Pfaller MA, Allen SD, et al. Antimicrobial activity of cefpirome: An update compared to five third-generation cephalosporins against nearly 6,000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis 1991;14:361-4.
4. Shungu DL, Ponticas S, Gill CJ. Comparative activity of cefoxitin, ampicillin/sulbactam and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumonia. Clin Ther 1989;11:315-8.
5. Aldridge KE, Sanders CV, Janney A, et al. Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother 1984;26:410-3.
6. Houghton GW, Thorne PS, Smith J, et al. Comparison of metronidazole in healthy volunteers following either a single oral or intravenous dose. Br J Clin Pharmacol 1979;8:337-41.
7. Bergan T, Bjerke P, Fausa O. Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers. Chemotherapy 1981;27:233-8.
8. Martin C, Sastre B, Mallet MN, et al. Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery. Antimicrob Agents Chemother 1991;35:2602-5.
9. Gorbach SL. Treatment of intra-abdominal infections. J Antimicrob Chemother 1993;31(Suppl A):67-78.
10. Freeman CD, Nightingale CH, Nicolau DP, Bellivue PP, et al. Bactericidal activity of low dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam. Pharmacotherapy 1994;14(suppl 2):15-90.
11. Freeman CD, Nightingale CH, Nicolau DP, et al. Serum bactericidal activity of ceftriaxone plus metronidazole against common intra-abdominal pathogens. Am J Health-Syst Pharm 1994;51:1782-7.
12. Quintiliani R, Nightingale CH, Bellivue P, Sullivan M. Cefotaxime plus metronidazole for intra-abdominal infection. P & T 1993;18:227-9.